In the second PCA plot the coloring allows one to see a clear separation between the B-ALL samples based on WHO Defining Alterations, namely those with a MLL gene rearrangement and those with an ETV6 fusion. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.